18
Participants
Start Date
June 1, 2019
Primary Completion Date
June 30, 2020
Study Completion Date
August 30, 2020
CDX 6114
CDX-6114 for oral administration is formulated in phosphate buffer, which also includes mannitol and poloxamer.The vehicle solution provided is identical to the CDX-6114 oral solution except for the active drug.
Matching Placebo
The placebo oral dosing solution will also be supplied as an approximately 240 mL oral solution and will be made up of the phosphate buffer diluent and the caramel flavoring.
Linear Clinical Research Ltd, Nedlands
Profil Institut für Stoffwechselforschung GmbH, Neuss
Société des Produits Nestlé (SPN)
INDUSTRY